Clinical trial
Immuno & Safety Study With 2 Formulations of DTPw-HBV/HIB When Given at Birth…
NCT00316680 · GlaxoSmithKline, Industry · Terminated
Key facts
| NCT number | NCT00316680 |
|---|---|
| Title | Immuno & Safety Study With 2 Formulations of DTPw-HBV/HIB When Given at Birth With Hepatitis B at 2, 4 and 6 Mths.Age. |
| Official title | Study to Assess Immunogenicity and Safety of GlaxoSmithKline Biologicals' Kft's DTPw-HBV/Hib vs DTPwCSL-HBV/Hib Kft and vs Concomitant Administration of CSL's Triple Antigen and GlaxoSmithKline Biologicals' Hiberix, to Infants at 2, 4, 6 Months of Age, After a Birth Dose of Hepatitis B |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Haemophilus Influenzae Type b, Diphtheria, Tetanus, Hepatitis B, Whole Cell Pertussis |
| Intervention type | Biological |
| Interventions | Diphtheria, tetanus, pertussis, hepatitis B, Hib vaccine |
| Enrollment | 288 |
| Start date | Mar 1, 2006 |
| Completion | Nov 1, 2006 |
| First posted | Apr 21, 2006 |
| Last update posted | Oct 7, 2016 |
| Countries | Dominican Republic |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: